Browse EX-10 agreements

AMENDMENT NO. 2 TO LOAN AND SECURITY AGREEMENT

THIS AMENDMENT NO. 2 TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of June 5, 2026 (the “Amendment Effective Date”), is entered into among PennantPark Investment Advisers, LLC, a Delaware limited liability company, as the collateral manager (the “Collateral Manager”), PennantPark Private Income Fund SPV LLC, a Delaware limited liability company, as the borrower (the “Borrower”), the Lenders party hereto, CIBC Bank USA, as the administrative agent (the “Administrative Agent”) and Western Alliance Trust Company, National Association, not in its individual capacity but as the collateral agent (the “Collateral Agent”) and as the document custodian (the “Document Custodian”).

…

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT OR OTHER APPLICABLE EXEMPTION. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

Principal Amount: US$300,000

Issue Date: June 3, 2026

Purchase Price: US$250,000.00

 

CONVERTIBLE NOTE

…

SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated and effective May 24, 2026, by and between EDGEMODE, INC**.,** a Nevada corporation, with headquarters located at 110 E. Broward Blvd., Suite 1700, Ft. Lauderdale, FL 33301 (the "Company") and IG Holdings Inc, with its address at 30 BILTMORE ESTATES - PHOENIX, AZ 85016, (the "Buyer").

 

WHEREAS:

 

A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the "SEC") under the Securities Act of 1933, as amended (the "1933 Act");

…

REGISTRATION RIGHTS AGREEMENT

 

This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 8, 2026 by and among LiqTech International, Inc., a Nevada corporation (the “Company”), and the “Investors” named in that certain Debt Cancellation and Exchange Agreement, dated as of May 26, 2026, by and among the Company and such Investors (the “Debt Cancellation Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Debt Cancellation Agreement unless otherwise defined herein.

 

The parties hereby agree as follows:

 

1.    Certain Definitions.

 

As used in this Agreement, the following terms shall have the following meanings:

 

“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Investors” means the Investors set forth on Schedule I of the Debt Cancellation Agreement.

…

REDEMPTION AGREEMENT

 

This Redemption Agreement (this “Agreement”) is entered into as of June 3, 2026 (the “Effective Date”), by and between Super League Enterprise, Inc., a Delaware corporation (“SLE” or the “Company”), on the one hand, and Yield Point NY, LLC, a New York limited liability company (“YP” or the “Holder”), on the other hand. SLE and YP are each referred to herein as a “Party” and collectively as the “Parties.”

 

RECITALS

 

WHEREAS, YP is the registered holder of 1,153 shares of Series C Convertible Preferred Stock of SLE (the “Series C Preferred Stock”), having an aggregate stated value of one million one hundred fifty-three thousand dollars ($1,153,000.00) (the “Stated Value”);

 

WHEREAS, SLE and YP previously entered into an Equity Line of Credit arrangement providing for up to twenty million dollars ($20,000,000.00) (the “ELOC”).

 

WHEREAS, SLE desires to redeem all 1,153 shares of Series C Preferred Stock held by YP, and YP desires to have such shares redeemed, on the terms and subject to the conditions set forth in this Agreement; and

…

Document

Exhibit 10.1

Quanterix

900 Middlesex Turnpike | Building 1

Billerica, MA 01821

Jason Faessler

Delivered via Email

Re: Employment Agreement

Dear Jason:

Quanterix Corporation (the "Company") is pleased to offer you the full-time, exempt position of Chief Financial Officer, reporting to Everett Cunningham, Chief Executive Officer. Your start date will be June 22, 2026. This role is required to be in our Billerica, MA office.

Congratulations on this offer and career opportunity with Quanterix!

1. Base Salary: The Company will pay you a salary at an annual rate of $475,000.00, paid at a bi-weekly rate of $18,269.23 (less all applicable taxes and deductions), subject to periodic review and adjustment at the discretion of the Company.

…

June 8, 2026

 

Jared Oasheim 

joasheim@cvrx.com

 

Re:           Employment Transition Agreement

 

Dear Jared,

 

I want to thank you for your service to CVRx, Inc. (the “Company”). I understand you have chosen to transition from CVRx and appreciate your willingness to effect a smooth transition as outlined in this letter agreement (“Agreement”).

 

1.             Transition and Resignation from Employment. You hereby confirm your resignation as an officer of the Company and any of its subsidiaries and affiliates, effective as of the end of the day on the day preceding the Officer Transition Date (as outlined below), and your resignation as an employee of the Company as of the Separation Date (as outlined below). You agree to continue to serve as the Chief Financial Officer of the Company until the Officer Transition Date. The “Officer Transition Date” is the date on which your successor as Chief Financial Officer commences employment with the Company in such role, or such other date as the Company determines to initiate a transition of your officer role. Th

…

​

​

​

​

​

Exhibit 10.1

​

SECURITIES PURCHASE AGREEMENT

​

This Securities Purchase Agreement (this “Agreement”) is dated as of June 5, 2026, between Aspira Women’s Health, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature page hereto (including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

​

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

​

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

​

…

EXECUTION VERSION

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS AS PRIVATE AND CONFIDENTIAL. REDACTED INFORMATION IS INDICATED BY [***]

 

 

 

LIMITED LIABILITY COMPANY AGREEMENT

 

OF

 

SOLUNA MB KK II JVCO, LLC

 

Dated as of June 3, 2026

 

 

 

THE LIMITED LIABILITY COMPANY INTERESTS REPRESENTED BY THIS LIMITED LIABILITY COMPANY AGREEMENT HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR UNDER ANY OTHER APPLICABLE FEDERAL OR STATE SECURITIES LAWS. SUCH INTERESTS MAY NOT BE SOLD, ASSIGNED, PLEDGED OR OTHERWISE DISPOSED OF AT ANY TIME WITHOUT EFFECTIVE REGISTRATION UNDER SUCH ACT AND LAWS OR EXEMPTION THEREFROM, AND COMPLIANCE WITH THE OTHER RESTRICTIONS ON TRANSFERABILITY SET FORTH HEREIN.

 

 

 

TABLE OF CONTENTS

 

 

 

Page

 

 

 

ARTICLE I

DEFINITIONS

2

 

 

 

ARTICLE II

ORGANIZATION

2

 

 

 

2.01.

Formation

2

2.02.

Name

2

2.03.

Registered Agent; Registered Office

…

Execution Version

TENDER AND SUPPORT AGREEMENT

This TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of June [•], 2026, is entered into by and among GlaxoSmithKline LLC, a Delaware limited liability company (“Parent”), Harmony Row Acquisition Co., a Delaware corporation and a wholly-owned subsidiary of Parent (“Purchaser”), and one or more stockholders of Nuvalent, Inc., a Delaware corporation (the “Company”), set forth on Schedule A hereto (each, a “Stockholder” and, if applicable, collectively, the “Stockholders”). All terms used but not otherwise defined in this Agreement shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).

…